Primary Biliary Cholangitis Learning Center

Faculty

Course Director

Marlyn Mayo, MD

Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Marlyn Mayo, MD, is a professor of internal medicine at UT Southwestern Medical Center and a member of its Division of Digestive and Liver Diseases. She earned her medical degree from Baylor College of Medicine in Houston, Texas; completed her internship and residency in internal medicine at University of California–Irvine; and completed a fellowship in gastroenterology/hepatology at UT Southwestern Medical Center.

The focus of Dr. Mayo’s research is on the pathogenesis of autoimmune liver diseases—at present, the molecular events involved in bile duct damage in primary biliary cirrhosis and development of cryoglobulins in hepatitis C are areas of investigation. She also conducts clinical trials in the UT Southwestern General Clinical Research Center investigating new treatments for primary biliary cirrhosis.

Dr. Mayo has been involved in setting the standards for medical education, and has been both the associate program director and program director of the Gastroenterology Fellowship program at UT Southwestern. Additionally, she is a member of several professional societies, including the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association, the Texas Medical Association, the Dallas County Medical Society, and the American College of Gastroenterology. She has served on multiple committees for the AASLD in the areas of research and education.

Dr. Mayo has been included in D Magazine’s Best Doctors list on numerous occasions.

Course Faculty

Aparna Goel, MD

Clinical Associate Professor of Medicine
Division of Gastroenterology & Hepatology
Stanford University
Palo Alto, California

Aparna Goel, MD, obtained her medical degree from Jefferson Medical College and subsequently completed her internal medicine residency at the University of California–San Francisco. She completed gastrointestinal and transplant hepatology fellowships at Mount Sinai in New York and then joined faculty at Stanford University, where she is currently an associate professor.

At Stanford, Dr. Goel is a transplant hepatologist with a specific clinical and research interest in autoimmune liver diseases, including autoimmune hepatitis, primary sclerosing cholangitis, and primary biliary cholangitis, and serves as the principal investigator on several clinical trials related to these diseases. She is the program director of the Accreditation Council for Graduate Medical Education (ACGME) Transplant Hepatology Fellowship and the associate program director of the Gastroenterology Fellowship at Stanford.

Stuart C. Gordon, MD

Professor of Medicine
Wayne State University School of Medicine
Professor of Medicine
Michigan State University College of Medicine
Detroit, Michigan

Stuart C. Gordon, MD, is a professor of medicine at both Wayne State University School of Medicine and Michigan State University College of Human Medicine. He received his training in clinical hepatology at the University of Miami.

Dr. Gordon is the principal investigator of the U.S. Fibrotic Liver Disease (FoLD) study, a large multicenter consortium that examines the epidemiology and natural history of primary biliary cholangitis (PBC) in the United States.

Dr. Gordon has served as an ad-hoc member on several National Institutes of Health (NIH) and National Cancer Institute (NCI) study sections, is on the data and monitoring board for the Drug Induced Liver Injury Network (DILIN), is on the Global NASH Council, and serves on the board of directors for Liver Health International.

Dr. Gordon was the recipient of the Distinguished Alumni Award from Wayne State University School of Medicine and is a Laureate of the Michigan Chapter of the American College of Physicians. He was an appointed member of the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America (AASLD-IDSA) Hepatitis C Guidance Committee, and served on the editorial board of Clinical Gastroenterology and Hepatology. He has authored or coauthored more than 350 papers, reviews, editorials, and book chapters.